Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
Advisory Committees Vaccines Regulation

Flu Vaccine Potency Remains Top Of Mind As US Panel Prepares To Pick Next Season's Strains

  • Analysis

Executive Summary

FDA advisory committee will vote on WHO's flu strain recommendations as agency hunts for root causes of low effectiveness of current season’s vaccine. 

You may also be interested in...



Universal Flu Vaccine Is Still Several Years Away, Fauci Says

Developing a universal flu vaccine will be iterative process, National Institute of Allergy and Infectious Diseases Anthony Fauci says.

Eggs May Be Culprit In Poor Flu Vaccine Performance This Year

US health authorities, manufacturers investigating why egg-based product appears to have lower effect in adults compared to cell-based flu vaccine.

Hahn's Nomination Heads To Full Senate Following Bipartisan Endorsement From HELP Committee

The Senate HELP Committee votes 18-5 to send Stephen Hahn's nomination to head the US FDA to the full chamber, although a few senators raised concerns over Hahn's responses to questions about e-cigarettes during his confirmation hearing. 

Table

View full table

Topics

Related Companies

Tags:
Advisory Committees Vaccines Regulation
UsernamePublicRestriction

Register

PS122604

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By